Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine

Pathophysiology

Volumn 16, Issue 4, 2009, Pages 259-265

  Huang, Yu Shan ^a   Zhi, Yan Fang ^b   Wang, Shu Ren ^c  

^a Jingangshan University   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Atherosclerosis; DNA methylation; Estrogen receptor ; Homocysteine

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GENOMIC DNA; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROGENESIS; ATHEROMATOSIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; DISEASE SEVERITY; DNA DETERMINATION; DNA METHYLATION; ECHOGRAPHY; FEMALE; GENE FREQUENCY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SMOOTH MUSCLE FIBER;

EID: 69249217999     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2009.02.010     Document Type: Article

References (20)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Schwartz S.M., Majesky M.W., and Murry C.E. The intima development and monoclonal responses to injury. Atherosclerosis 118 (1995) S125-140
3. Hulley S., Grady D., Bush T., Furberg C., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: heart and estrogen/progestin replacement study (HERS) research group. JAMA 280 (1998) 605-613
4. Graham I.M., Daly L.E., Refsum H., Robinson K., Brattström L.E., Ueland P.M., et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 277 (1997) 1775-1781
5. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 49 (2003) 1292-1296
6. James S.J., Melnyk S., Pogribna M., Pogribny I.P., and Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 132 (2002) 2361S-2366S
7. Eikelboom J.W., Lonn E., Genest J.J., et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Int. Med. 131 (1999) 363-375
8. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 (2003) 245-254
9. Sado T., Fenner M.H., Tan S.S., Tam P., Shioda T., and Li E. X Inactivation in the mouse embryo deficient for dnmt1: distinct effect of hypomethylation on imprinted and random X inactivation. Dev. Biol. 225 (2000) 294-303
10. Bruce R. DNA methylation and autoimmune disease. Clin. Immunol. 109 (2003) 72-79
11. Bruce R. Impact of aging on DNA methylation. Aging Res. Rev. 2 (2003) 245-261
12. Chunming D., Woohyun Y., Pascal J., et al. DNA methylation and atherosclerosis. J. Nutr. 132 (2002) 2406S-2409S
13. Crouse J.R., Harpold G.H., Kahl F.R., et al. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound [J]. Stroke 17 (1986) 270-276
14. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., et al. Methylation on the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43 (1999) 985-991
15. Guilland J.-C., Favier A.P., et al. Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. Pathol. Biol. 51 (2003) 101-110
16. Kathy K.W.A.-Y., Connie W.H.W., et al. Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ. Res. 94 (2004) 28-36
17. Mikko O.H., Mikko P.T., Tomi P.H., et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc. Med. 7 (2002) 5-11
18. Shahjehan A.W., Peter W.L., and Tom R.D. DNA methylation: an alternative pathwayto cancer. Ann. Surg. 234 (2001) 10-20
19. Jiang Y., Zhang J., Huang Y., et al. Homocysteine-mediated expression of SAHH, DNMTs, MBD2 and DNA hypomethylation, potential pathogenic mechanism in VSMCs. DNA Cell Biol. 26 (2007) 603-611
20. Malinow M.R., and Bostom Aq Krauss R.M. Homocysteine, diet and cardiovascular disease. A statement for health care professionals from the nutrition committee, American Heart Association [AHA Science Advisory]. Circulation 99 (1999) 178